Kutshanje, amajelo eendaba aphesheya uFierce Medtech ukhethe eyona 15 intsha kakhuluiinkampani zezixhobo zonyangongo 2023. Ezi nkampani azigxininisi kuphela kwezona ndawo zixhaphakileyo zobugcisa, kodwa zikwasebenzisa ingqiqo yazo ukufumanisa iimfuno zonyango ezinokubakho.
01
Uqhaqho olusebenzayo
Nika oogqirha botyando ulwazi olubonakalayo lwexesha lokwenyani
I-CEO: Manisha Shah-Bugaj
Yasekwa: 2017
Indawo: eBoston
I-Active Surgical igqibe utyando lokuqala oluzisebenzelayo lwerobhothi kwihlabathi kwiithishu ezithambileyo.Inkampani ifumene imvume ye-FDA kwimveliso yayo yokuqala, i-ActiveSight, imodyuli yotyando ehlaziya ngoko nangoko idatha yokucinga.
I-ActiveSight isetyenziswa ngamaziko amalunga neshumi elinesibini e-United States ukwenza utyando lwe-colorectal, thoracic kunye ne-bariatric, kunye neenkqubo ngokubanzi ezifana nokususwa kwenyongo.Uninzi lwe-robotic prostatectomies luye lwenziwa kusetyenziswa i-ActiveSight.
02
Beta Bionics
Revolutionary Artificial Pancreas
I-CEO: Sean Saint
Yasekwa: 2015
Indawo: Irvine, California
Iinkqubo zokuhanjiswa kwe-insulin ezizenzekelayo zonke zinomsindo kwihlabathi letekhnoloji yeswekile.Inkqubo, eyaziwa ngokuba yinkqubo ye-AID, yakhiwe malunga ne-algorithm ethatha ukufundwa kwe-glucose yegazi kwi-monitor ye-glucose eqhubekayo, kunye nolwazi malunga nokuthathwa kwe-carbohydrates yomsebenzisi kunye namanqanaba omsebenzi, kwaye iqikelela loo manqanaba kwimizuzu embalwa ezayo.utshintsho olunokuthi lwenzeke ngaphakathi kwempompo ye-insulin ngaphambi kokulungelelanisa i-insulin pump output ukuphepha i-hyperglycemia eqikelelwayo okanye i-hypoglycemia.
Le ndlela yobuchwepheshe obuphezulu idala into ebizwa ngokuba yi-hybrid-closed-loop system, okanye i-pancreas eyenziweyo, eyenzelwe ukunciphisa izandla kumsebenzi we-diabetics.
I-Beta Bionics ithatha le njongo inyathelo elinye ukuya phambili ngeteknoloji ye-iLet bionic pancreas.Inkqubo ye-iLet ifuna kuphela ubunzima bomsebenzisi ukuba bufakwe, ukuphelisa imfuno yokubala okunzima kwe-carbohydrate intake.
03
Impilo yaseCala
Kukuphela konyango olunxitywayo kwihlabathi lokungcangcazela
Co-Chairs: Kate Rosenbluth, Ph.D., Deanna Harshbarger
Yasekwa: 2014
Indawo: San Mateo, California
Izigulana ezinokungcangcazela okuyimfuneko (ET) kudala zingenalo unyango olusebenzayo, olunomngcipheko ophantsi.Izigulana zinokwenza utyando lwengqondo oluhlaselayo kuphela ukufaka isixhobo esinzulu sokuvuselela ingqondo, kaninzi sineziphumo ezingephi, okanye amayeza anyiniweyo aphatha kuphela iimpawu kodwa hayi unobangela, kwaye anokubangela iziphumo ebezingalindelekanga ezimandundu.
I-Silicon Valley yokuqalisa iCala Health iphuhlise isixhobo esinxitywayo sokungcangcazela okubalulekileyo esinokuhambisa unyango lwe-neuromodulation ngaphandle kokwaphula ulusu.
Isixhobo senkampani yeCala ONE savunywa okokuqala yi-FDA ngo-2018 kunyango lodwa lokungcangcazela okubalulekileyo.Ehlotyeni elidlulileyo, iCala ONE yaphehlelela isizukulwana sayo esilandelayo nge-510(k) imvume: I-Cala kIQ™, isixhobo sokuqala kunye nekuphela kwe-FDA evunyiweyo ephathwa ngesandla ebonelela ngonyango lwesandla olusebenzayo kwizigulana ezinokungcangcazela okuyimfuneko kunye nesifo sikaParkinson.Isixhobo esinxitywayo sonyango loncedo lokungcangcazela.
04
Causly
Ukuguqula uPhando lwezonyango
I-CEO: Yiannis Kiachopoulos
Yasekwa: 2018
Indawo: London
I-Causaly iphuhlise oko i-Kiachopoulos ibiza ngokuthi "inqanaba lokuqala lokuvelisa i-AI co-pilot" eyenza izazinzulu zikhawuleze ukukhangela ulwazi.Izixhobo ze-AI ziya kubuza yonke into epapashiweyo yophando lwe-biomedical kwaye inike iimpendulo ezipheleleyo kwimibuzo enzima.Oku ke kunceda iinkampani eziphuhlisa amachiza ukuba zithembele ngakumbi kukhetho abazenzayo, njengoko abathengi besazi ukuba isixhobo siya kunika ulwazi olupheleleyo malunga nommandla wesifo okanye itekhnoloji.
Into ekhethekileyo malunga neCausaly kukuba nabani na unokuyisebenzisa, kunye nabantu abaqhelekileyo.
Okona kulungileyo, abasebenzisi akufuneki bafunde lonke uxwebhu ngokwabo.
Olunye uncedo lokusebenzisa i-Causaly kukuchonga iziphumo ezinokuthi zibekho ukuze iinkampani zikwazi ukuphelisa usukelo.
05
Element Biosciences
Umngeni unxantathu ongenakwenzeka womgangatho, iindleko kunye nokusebenza kakuhle
CEO: Molly He
Yasekwa: 2017
Indawo: eSan Diego
Inkqubo ye-Aviti yenkampani iya kuqala ekuqaleni kwe-2022. Njengesixhobo sobungakanani bedesktop, iqulethe iiseli ezimbini zokuhamba ezinokusebenza ngokuzimeleyo, ukunciphisa kakhulu iindleko zokulandelelana.I-Aviti24, ekulindeleke ukuba iqalise kwisiqingatha sesibini salo nyaka, yenzelwe ukubonelela ngokuphuculwa koomatshini abafakelweyo ngoku kwaye bajike babe ziiseti zehardware ezikwaziyo ukucazulula kungekuphela nje i-DNA kunye ne-RNA, kodwa neeproteni kunye nolawulo lwazo, kunye ne-cell morphology. .
06
Vulela uKutofa
Ukulawulwa ngomthambo nanini na, naphi na
I-CEO: UMike Hooven
Yasekwa: 2010
Ifumaneka eCincinnati
Njengenkampani yetekhnoloji yezonyango ngaphezulu kweshumi leminyaka ekwenzeni, i-Able Injections yenza imitsi kutshanje.
Oku kuwa, inkampani ifumene isixhobo sayo sokuqala esivunyiweyo se-FDA, isixhobo se-EMPAVELI esitofwayo, esilayishwe nge-Pegcetacoplan, unyango lokuqala olujoliswe kwi-C3 ukunyanga i-PNH (i-paroxysmal nocturnal hemoglobinuria).I-Pegcetacoplan yonyango lokuqala oluvunyiweyo lwe-FDA lwe-2021. Unyango olujoliswe kwi-C3 kunyango lwe-PNH ikwalichiza lokuqala kwihlabathi elivunyiweyo ukunyanga i-macular geographic atrophy.
Ulwamkelo luvuthondaba lweminyaka yokusebenza yinkampani kwizixhobo zokuhanjiswa kweziyobisi eziyilelwe ukuba zilungele isigulane ngelixa zivumela ukulawulwa ngomthambo weedosi ezinkulu.
07
Ekso
Ixesha elitsha le-ultrasound ephathwayo
CEO: andeep Akkaraju
Yasekwa: 2015
Indawo: Santa Clara, California
I-Exo Iris, isixhobo esiphathwa ngesandla se-ultrasound esasungulwa ngu-Exo ngoSeptemba ka-2023, yanconywa “njengexesha elitsha le-ultrasound” ngelo xesha, kwaye yafaniswa nophando oluphathwa ngesandla olusuka kwiinkampani ezifana ne-GE Healthcare kunye neButterfly Network.
I-Iris ephathwayo ephathwayo ithatha imifanekiso ene-150-degree field of view, ethi inkampani ingakwazi ukugubungela isibindi sonke okanye i-fetus yonke ukuya kubunzulu be-30 centimeters.Ungatshintsha kwakhona phakathi koluhlu olugobileyo, olunomgca okanye olunezigaba, ngelixa iinkqubo ze-ultrasound eziqhelekileyo zifuna iiprobes ezahlukeneyo.
08
Genesis Therapeutics
AI Pharmaceutical Rising Star
I-CEO: Evan Feinberg
Yasekwa: 2019
Indawo: Palo Alto, California
Ukubandakanya ukufunda koomatshini kunye nobukrelekrele bokwenziwa kuphuhliso lwamachiza yindawo enkulu yotyalo-mali kwishishini le-biopharmaceutical.
IGenesis ijolise ekwenzeni oku ngeqonga layo le-GEMS, isebenzisa inkqubo entsha eyakhiwe ngabaseki benkampani ukuyila iimolekyuli ezincinci, kunokuthembela kwiinkqubo ezikhoyo zokuyilwa kweekhemikhali.
I-GEMS yeGenesis Therapeutics (i-Genesus Exploration of Molecular Space) idibanisa iimodeli eziqikelelwayo ezisekelwe kufundo olunzulu, ukulinganisa iimolekyuli kunye neemodeli zolwimi lokuqonda iikhemikhali, ngethemba lokudala amachiza emolekyuli amancinci “akwiklasi yokuqala” anamandla aphezulu kakhulu kunye nokukhetha., ngakumbi ukujolisa kwiithagethi ebezingenakusebenziseka ngaphambili.
09
Ukuqukuqela kwentliziyo
Inkokeli yeFFR
I-CEO: UJohn Farquhar
Yasekwa: 2010
Indawo: Mountain View, California
I-HeartFlow yinkokeli kwi-Fractional Flow Reserve (FFR), inkqubo echitha i-3D CT angiography scans yentliziyo ukuchonga i-plaque kunye ne-blockages kwi-coronary arteries.
Ngokubonelela ngokubonwa kokuhamba kwegazi oksijini ukuya kwisihlunu sentliziyo kunye nokulinganisa ngokucacileyo iindawo zemithambo yegazi ethintelweyo, inkampani iye yaseka indlela yobuqu yokungenelela kwiimeko ezifihlakeleyo ezibangela amashumi ezigidi zeentlungu zesifuba kunye nokuhlaselwa yintliziyo minyaka le. amatyala okuhlutha.
Eyona njongo yethu iphambili kukwenza isifo sentliziyo into esiyenzela umhlaza ngokuhlolwa kwangoko kunye nonyango lobuqu, ukunceda oogqirha ukuba benze izigqibo ezizizo ezisekelwe kwiimfuno zesigulana ngasinye.
10
Karius
Ukulwa nosulelo olungaziwayo
I-CEO: Alec Ford
Yasekwa: 2014
Indawo: Redwood City, California
Uvavanyo lwe-Karius yinoveli yetekhnoloji yolwelo lwe-biopsy enokubona ngaphezulu kwe-1,000 yeentsholongwane ezosulelayo kwigazi elinye kwiiyure ezingama-26.Uvavanyo lunokunceda oogqirha banqande uxilongo oluninzi oluhlaselayo, banciphise amaxesha okujika, kwaye banqande ukulibaziseka ekunyangeni abaguli abalaliswe esibhedlele.
11
ILinus Biotechnology
Iinwele ezi-1cm zokuxilonga i-autism
I-CEO: UGqr Manish Arora
Yasekwa: 2021
Indawo: Mantla Brunswick, eNew Jersey
I-StrandDx inokukhawulezisa inkqubo yokuvavanya kunye nekiti yokuvavanya ekhaya efuna nje ukuba i-strand yeenwele ibuyiselwe kwinkampani ukugqiba ukuba i-autism inokukhutshwa ngaphandle.
12
Namida Lab
Iinyembezi zikhusela umhlaza wamabele
I-CEO: Omid Moghadam
Yasekwa: 2019
Indawo: Fayetteville, Arkansas
I-Auria luvavanyo lokuqala lokuhlola umhlaza webele olusekwe kwiinyembezi ekhaya olungeyondlela yokuxilonga kuba aluboneleli ngesiphumo sesibini esixela ukuba umhlaza wamabele ukhona na.Kunoko, amaqela aphumela kwiindidi ezintathu ngokusekelwe kumanqanaba eeprotheyini ezimbini ze-biomarkers kwaye icebisa ukuba umntu kufuneka afune ukuqinisekiswa ngakumbi kwi-mammogram ngokukhawuleza.
13
UNowa Medical
kwimiphunga biopsy nova
CEO: Zhang Jian
Yasekwa: 2018
Indawo: San Carlos, California
UNowa Medical wanyusa i-150 yezigidi zeedola kulo nyaka uphelileyo ukunceda inkqubo ye-bronchoscopy ekhokelwa ngumfanekiso weGalaxy ukukhuphisana nezigebenga ezimbini zeshishini, iqonga le-Intuitive Surgical's Ion kunye ne-Johnson & Johnson's Monarch.
Zontathu izixhobo ziyilwe njengophando olubhityileyo olungena ngaphandle kwimiphunga yebronchi kunye neepaseji, ukunceda oogqirha botyando ukuba bakhangele izilonda kunye namaqhuqhuva ekurhaneleka ukuba afihle amathumba omhlaza.Nangona kunjalo, uNowa, njengomntu ofike emva kwexesha, wafumana imvume ye-FDA ngoMatshi ka-2023.
NgoJanuwari walo nyaka, inkqubo yeGalaxy yenkampani igqibezele itshekhi yayo engama-500.
Into enkulu ngoNowa kukuba inkqubo isebenzisa iinxalenye ezilahlayo ngokupheleleyo, kwaye yonke inxalenye edibana nesigulane inokulahlwa kwaye ifakwe kwi-hardware entsha.
14
Iprocyrion
Ukuphelisa unyango lwentliziyo kunye nesifo sezintso
IGosa eliLawulayo eliyiNtloko: U-Eric Fain, MD
Yasekwa: 2005
Indawo: Houston
Kwabanye abantu abanesifo senhliziyo, i-feedback loop ebizwa ngokuba yi-cardiorenal syndrome yenzeka, apho izihlunu zentliziyo ezibuthathaka ziqala ukuhla ekukwazini ukucima ulwelo olusuka emzimbeni xa izihlunu zentliziyo ezibuthathaka zingakwazi ukuthwala igazi kunye ne-oksijini kwizintso.Oku kufumba kolwelo, kwandisa ubunzima bokubetha kwentliziyo.
I-Procyrion ijolise ekuphazamiseni le ngxelo kunye nepompo ye-Aortix, isixhobo esincinci, esisekelwe kwi-catheter esingena kwi-aorta yomzimba ngesikhumba kunye nezantsi ngesifuba kunye nesisu.
Isebenza ngokufana nezinye iimpompo zentliziyo ezisekelwe kwi-impeller, ukuyibeka embindini weyona mithambo mikhulu yomzimba ngaxeshanye ikhulula umthwalo womsebenzi kwintliziyo ephezulu kwaye iququzelele ukuhamba kwegazi ezantsi ukuya kwizintso.
15
Iproprio
Yenza imephu yotyando
I-CEO: uGabriel Jones
Yasekwa: 2016
Ifumaneka kwi: Seattle
I-Paradigm, inkampani ye-Proprio, iqonga lokuqala lokusebenzisa iteknoloji yentsimi yokukhanya kunye nobukrelekrele bokufakelwa ukuvelisa imifanekiso ye-3D yexesha langempela ye-anatomy yesigulane ngexesha lotyando ukuxhasa utyando lomqolo.
Ixesha lokuposa: Mar-28-2024